111 In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment-Reference-Cited by-同舟云学术

111 In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment

Published:2014-07 Issue:5 Volume:13 Page:7290.2014.00011
ISSN:1536-0121
Container-title:Molecular Imaging
language:en
Short-container-title:Mol Imaging

Author:

Gaykema Sietske B.M.¹,de Jong Johan R.¹,Perik Patrick J.¹,Brouwers Adrienne H.¹,Schröder Carolien P.¹,Munnink Thijs H. Oude¹,Bongaerts Alphons H.H.¹,de Vries Elisabeth G.E.¹,Hooge Marjolijn N. Lub-de¹

Affiliation:

1. From the Departments of Medical Oncology, Nuclear Medicine and Molecular Imaging, Radiology, and Hospital and Clinical Pharmacy, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.

Publisher

SAGE Publications

Subject

Condensed Matter Physics,Radiology Nuclear Medicine and imaging,Biomedical Engineering,Molecular Medicine,Biotechnology

Link

http://journals.sagepub.com/doi/pdf/10.2310/7290.2014.00011

Reference19 articles.

1. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

2. Prognostic and predictive value ofHER2/neu oncogene in breast cancer

3. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

4. Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

5. registHER: A prospective, longitudinal cohort study of women with HER2 positive metastatic breast cancer

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Theranostics: Pharmaceutical View;Pharmaceutical Science;2024-08-21

2. Advances and challenges in immunoPET methodology;Frontiers in Nuclear Medicine;2024-02-19

3. Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [99mTc] Tc-Labeled Small Peptide;Clinical Breast Cancer;2023-02

4. Direct In Vivo Comparison of 99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy;International Journal of Molecular Sciences;2022-12-02

5. Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart;Pharmaceutics;2022-08-02